RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Source: JNCI - Category: Cancer & Oncology Authors: Toomey, S., Eustace, A. J., Pritzker, L. B., Pritzker, K. P. H., Fay, J., OGrady, A., Cummins, R., Grogan, L., Kennedy, J., OConnor, D., Young, L., Kay, E. W., ODonovan, N., Gallagher, W. M., Kalachand, R., Crown, J., Hennessy, B. T. Tags: Correspondence Source Type: research